| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:18 | Upstream Bio presents positive Phase 2 trial data for verekitug | ||
| 15:30 | Evercore ISI maintains Lennar stock rating on margin outlook | ||
| 11:54 | Ant Group tests AI assistant for Alipay as competition with WeChat intensifies | ||
| 11:30 | Celldex reports positive phase 1 data for CDX-622 antibody | ||
| 01:42 | Amazon concerns helped trigger U.S. restrictions on Anthropic AI models | ||
| Sa | Agios presents detailed mitapivat trial results for sickle cell | ||
| Sa | Rhythm Pharmaceuticals reports phase 2 PWS trial results | ||
| Sa | Intellia presents Phase 3 results for HAE gene therapy lonvo-z | ||
| Sa | Incyte reports positive Phase 3 trial results for lymphoma drug | ||
| Sa | Tata iPhone parts plant warned over wastewater pollution - Reuters | ||
| Sa | Geely to streamline operations, focus resources on Hong Kong-listed unit | ||
| Sa | Judge allows First Brands to advance liquidation plan backed by creditors | ||
| Sa | Arcadia Biosciences closes $4 million private placement | ||
| Sa | Cathie Wood's ARK sells AMD stock, buys SpaceX shares in major trade | ||
| Sa | OpenAI subpoenaed in multistate attorney general probe: WSJ | ||
| Sa | Prime Drink Group announces private placement up to C$2.2M | ||
| Sa | Atossa Therapeutics closes $4.5M registered direct offering | ||
| Sa | Heartland Express declares $0.02 quarterly dividend | ||
| Fr | NYSE American moves to delist TechCreate Group shares | ||
| Fr | Federal Signal facility unharmed by tornado, acquires Western Tech | ||
| Fr | Nutrien warns shareholders against discounted mini-tender offer | ||
| Fr | Laser Photonics regains Nasdaq compliance after filing delay | ||
| Fr | MicroVision applies to transfer to Nasdaq Capital Market | ||
| Fr | Liberty All-Star Equity Fund appoints Loomis Sayles as manager | ||
| Fr | Freedom Holding announces $300 million stock offering plan |